@ARTICLE{Mehrabani, author = {Gholizadeh, Azade and Mehrabani, Sanaz and Esmaeili Dooki, Mohammadreza and Haji Ahmadi, Mahmood and }, title = {Effect of a synbiotic on functional abdominal pain in childhood}, volume = {12}, number = {2}, abstract ={Background: One of the common functional gastrointestinal disorders in children is functional abdominal pain (FAP). The aim of the present study was to determine whether the administration of a synbiotic composed of fructo-oligosaccharides (FOS) and the seven types of beneficial bacteria is useful in FAP of childhood. Methods: In this placebo-controlled, double-blind trial, 4-15-year-old children who met the Rome III criteria for FAP were randomly divided to receive either synbiotic or placebo twice daily for 4 weeks. Primary outcome was at least 50% reduction in the number of pain episodes, and secondary outcomes were a decline of at least two scales in the pain duration and intensity based on Wong-Baker scale. Response to therapy was decrease of pain frequency/intensity. Results: A total of 67 children completed the trial (35 with synbiotic). Response rate was higher with synbiotic than placebo after four weeks (53.1 vs 11.4%; p<0.001), and synbiotic had significant superiority to placebo to relieve the duration (4.56±9.12 vs12±18.59, min/day, P=0.04), frequency (0.31±0.53vs 1.17±0.7, episode/Wk., P<.001) and intensity (2.38±2.29 vs 5.49±1.83, p<0.001) of abdominal pain. Conclusion: Synbiotic compared to placebo significantly decreased the intensity, frequency and duration of FAP in children. }, URL = {http://caspjim.com/article-1-2247-en.html}, eprint = {http://caspjim.com/article-1-2247-en.pdf}, journal = {Caspian Journal of Internal Medicine}, doi = {10.22088/cjim.12.2.194}, year = {2021} }